Brief: Codiak’S Engineered Exosomes Promote T Cell And Antibody Responses To Sars-Cov-2 In Vivo, Supporting The Potential For A Broadly Protective Pan-Beta Coronavirus And Variant Vaccine

Codiak BioSciences,.

02/12/2021 13:41

Dec 2 (Reuters) - Codiak BioSciences, Inc.  CDAK.O :
    * CODIAK’S ENGINEERED EXOSOMES PROMOTE T CELL AND ANTIBODY
RESPONSES TO SARS-COV-2 IN VIVO, SUPPORTING THE POTENTIAL FOR A
BROADLY PROTECTIVE PAN-BETA CORONAVIRUS AND VARIANT VACCINE

Source text for Eikon:  ID:nGNX3HD4Lt 
Further company coverage:  CDAK.O 

 ((Reuters.Briefs@thomsonreuters.com;))